Literature DB >> 17918152

Cigarette smoking and risk of borderline and invasive epithelial ovarian cancer.

Inger T Gram1, Tonje Braaten, Hans-Olov Adami, Eiliv Lund, Elisabete Weiderpass.   

Abstract

Studies regarding the association between smoking and risk of epithelial ovarian cancer (EOC) are inconsistent. The purpose of this study was to examine the association between smoking and EOC, overall and according to invasiveness and histological subtype in a cohort of women with a high proportion of smokers at enrollment. We followed 103,081 women, aged 30-50 years in 1991/1992, from the Norwegian-Swedish Women's Lifestyle and Health cohort. The women completed a questionnaire on personal characteristics and exposures at enrollment and were subsequently followed with linkages to national registers through December 31, 2004. We used Cox proportional hazard regression models to estimate hazard ratio (RR) of EOC with 95% confidence intervals (CIs) associated with different measures of smoking exposures adjusting for confounding variables. Altogether 343 [241 (70%) invasive and 102(30%) borderline] incident EOC cases were identified. Former [HR = 2.2(95% CI 1.0-4.7)] and current [HR = 2.7(95% CI 1.2-5.7)] smokers had a more than doubling in risk for borderline tumors compared to never smokers. Women who had smoked for more than 20 years had 3 times [HR = 3.1(95% CI 1.5-6.7)] the risk of borderline tumors compared to never smokers. A test for trend according to smoking status was almost significant for mucinous tumors (p-trend = 0.05). A significant dose response relationship was found according to smoking intensity [pack-years; (0-9, 0-14, >or= 15)] and duration [number of years; (0-10, 11-20, >or= 20)] for borderline and serous tumors (p-trends < 0.05). In conclusion, smoking may increase the risk of borderline EOC. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17918152     DOI: 10.1002/ijc.23108

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

Review 1.  Association between Cigarette Smoking and Histotype-Specific Epithelial Ovarian Cancer: A Review of Epidemiologic Studies.

Authors:  Aili Zhou; Albina N Minlikeeva; Sadat Khan; Kirsten B Moysich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-05-01       Impact factor: 4.254

2.  Cancer incidence attributable to tobacco in Alberta, Canada, in 2012.

Authors:  Abbey E Poirier; Anne Grundy; Farah Khandwala; Sierra Tamminen; Christine M Friedenreich; Darren R Brenner
Journal:  CMAJ Open       Date:  2016-10-13

3.  Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study.

Authors:  Hannah P Yang; Britton Trabert; Megan A Murphy; Mark E Sherman; Joshua N Sampson; Louise A Brinton; Patricia Hartge; Albert Hollenbeck; Yikyung Park; Nicolas Wentzensen
Journal:  Int J Cancer       Date:  2011-11-10       Impact factor: 7.396

4.  Cigarette smoking and the association with serous ovarian cancer in African American women: African American Cancer Epidemiology Study (AACES).

Authors:  Linda E Kelemen; Sarah Abbott; Bo Qin; Lauren Cole Peres; Patricia G Moorman; Kristin Wallace; Elisa V Bandera; Jill S Barnholtz-Sloan; Melissa Bondy; Kathleen Cartmell; Michele L Cote; Ellen Funkhouser; Lisa E Paddock; Edward S Peters; Ann G Schwartz; Paul Terry; Anthony J Alberg; Joellen M Schildkraut
Journal:  Cancer Causes Control       Date:  2017-05-02       Impact factor: 2.506

5.  Quality of life and sexual function in patients with borderline tumors of the ovary. A substudy of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) study group ROBOT study.

Authors:  Juliane Farthmann; Annette Hasenburg; Meike Weil; Christina Fotopoulou; Nina Ewald-Riegler; Oya du Bois; Fabian Trillsch; Sven Mahner; Hans-Georg Strauss; Pauline Wimberger; Alexander Reuss; Andreas du Bois
Journal:  Support Care Cancer       Date:  2014-07-05       Impact factor: 3.603

6.  Cigarette smoking and risk of colorectal cancer among Norwegian women.

Authors:  Inger T Gram; Tonje Braaten; Eiliv Lund; Loic Le Marchand; Elisabete Weiderpass
Journal:  Cancer Causes Control       Date:  2009-03-10       Impact factor: 2.506

7.  Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts.

Authors:  Simone P Pinheiro; Shelley S Tworoger; Daniel W Cramer; Bernard A Rosner; Susan E Hankinson
Journal:  Am J Epidemiol       Date:  2009-04-02       Impact factor: 4.897

Review 8.  Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies.

Authors:  V Beral; K Gaitskell; C Hermon; K Moser; G Reeves; R Peto
Journal:  Lancet Oncol       Date:  2012-08-03       Impact factor: 41.316

9.  The hazards of death by smoking in middle-aged women.

Authors:  Inger T Gram; Sven Sandin; Tonje Braaten; Eiliv Lund; Elisabete Weiderpass
Journal:  Eur J Epidemiol       Date:  2013-10       Impact factor: 8.082

10.  Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies.

Authors:  Mette T Faber; Susanne K Kjær; Christian Dehlendorff; Jenny Chang-Claude; Klaus K Andersen; Estrid Høgdall; Penelope M Webb; Susan J Jordan; Mary Anne Rossing; Jennifer A Doherty; Galina Lurie; Pamela J Thompson; Michael E Carney; Marc T Goodman; Roberta B Ness; Francesmary Modugno; Robert P Edwards; Clareann H Bunker; Ellen L Goode; Brooke L Fridley; Robert A Vierkant; Melissa C Larson; Joellen Schildkraut; Daniel W Cramer; Kathryn L Terry; Allison F Vitonis; Elisa V Bandera; Sara H Olson; Melony King; Urmila Chandran; Lambertus A Kiemeney; Leon F A G Massuger; Anne M van Altena; Sita H Vermeulen; Louise Brinton; Nicolas Wentzensen; Jolanta Lissowska; Hannah P Yang; Kirsten B Moysich; Kunle Odunsi; Karin Kasza; Oluwatosin Odunsi-Akanji; Honglin Song; Paul Pharaoh; Mitul Shah; Alice S Whittemore; Valerie McGuire; Weiva Sieh; Rebecca Sutphen; Usha Menon; Simon A Gayther; Susan J Ramus; Aleksandra Gentry-Maharaj; Celeste Leigh Pearce; Anna H Wu; Malcolm C Pike; Harvey A Risch; Allan Jensen
Journal:  Cancer Causes Control       Date:  2013-03-02       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.